Filing Details

Accession Number:
0000791908-15-000101
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-28 17:44:07
Reporting Period:
2015-10-26
Filing Date:
2015-10-28
Accepted Time:
2015-10-28 17:44:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 942756657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222790 Phd Md J Patrick Scannon C/O Xoma Corporation
2910 Seventh Street
Berkeley CA 94710
Exec. Vp & Cso Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2015-10-26 8,000 $1.04 118,227 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 25,080 Indirect by 401(k)
Common Shares 750 Indirect by Daughter
Common Shares 4,053 Indirect by Trust
Footnotes
  1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2015.
  2. This transaction was executed in multiple trades ranging at prices from $1.04 to $1.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected.